Zobrazeno 1 - 10
of 650
pro vyhledávání: '"Berdejo J"'
Autor:
Lorenzo-Esteller L; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain., Ramos-Polo R; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Bio-Heart Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Pons Riverola A; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Bio-Heart Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Morillas H; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Bio-Heart Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Berdejo J; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Pernas S; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Pomares H; Clinical Haematology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Asiain L; Radiation Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Garay A; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Bio-Heart Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Preclinical and Experimental Research in Thoracic Tumors (PRETT), Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Martínez Pérez E; Radiation Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Jiménez-Marrero S; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Bio-Heart Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto Salud Carlos III, 28029 Madrid, Spain., Alcoberro L; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Nadal E; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Preclinical and Experimental Research in Thoracic Tumors (PRETT), Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Gubern-Prieto P; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Gual-Capllonch F; Cardiology Department, Hospital Universitari Son Espases, 07120 Palma, Spain., Hidalgo E; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Enjuanes C; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto Salud Carlos III, 28029 Madrid, Spain., Comin-Colet J; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto Salud Carlos III, 28029 Madrid, Spain.; Department of Clinical Sciences, School of Medicine, Universitat de Barcelona (UB), L'Hospitalet de Llobregat, 08036 Barcelona, Spain., Moliner P; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Bio-Heart Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto Salud Carlos III, 28029 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Oct 12; Vol. 16 (20). Date of Electronic Publication: 2024 Oct 12.
Autor:
Pons-Riverola A; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Morillas H; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Berdejo J; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Pernas S; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Pomares H; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Clinical Haematology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Asiain L; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Radiation Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Garay A; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Fernandez-Ortega A; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Oliveira AC; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Clinical Haematology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Haematopoietic and Lymphoid Tumours Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Martínez E; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Radiation Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Radiobiology and Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Jiménez-Marrero S; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain., Pina E; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Thrombosis and Haemostasis Unit, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain., Fort E; Pharmacy Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Ramos R; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Alcoberro L; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Hidalgo E; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain., Antonio-Rebollo M; Oncogeriatrics Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Alcober L; Primary Care Service Delta del Llobregat and IDIAP, Catalan Health Service, 08007 Barcelona, Spain., Enjuanes Grau C; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain., Comín-Colet J; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain., Moliner P; Cardio-Oncology Unit, Bellvitge University Hospital-Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Dec 18; Vol. 15 (24). Date of Electronic Publication: 2023 Dec 18.
Autor:
Kaplinsky, E., González-Costello, J., Manito, N., Roca, J., Barbosa, M.J., Nebot, M., Salazar-Mendiguchia, J., Berdejo, J., Mañas, P., Miralles, A., Cequier, A.
Publikováno v:
In Transplantation Proceedings November 2012 44(9):2564-2566
Autor:
Kania-Olejnik, Paulina1 (AUTHOR), Malinowski, Marcin1,2 (AUTHOR) marmal@interia.pl, Rausch, Manuel K.3 (AUTHOR), Timek, Tomasz A.2 (AUTHOR)
Publikováno v:
PLoS ONE. 10/3/2024, Vol. 19 Issue 10, p1-14. 14p.
Autor:
Iliakis, Panagiotis1 (AUTHOR) panayiotisiliakis@gmail.com, Dimitriadis, Kyriakos1 (AUTHOR) dimitriadiskyr@yahoo.gr, Pyrpyris, Nikolaos1 (AUTHOR) e.beneki@hotmail.com, Beneki, Eirini1 (AUTHOR) panos.theofilis@hotmail.com, Theofilis, Panagiotis1 (AUTHOR) conazna@yahoo.com, Tsioufis, Panagiotis1 (AUTHOR) ntina.aggeli@gmail.com, Kamperidis, Vasileios2 (AUTHOR) vkamperidis@yahoo.co.uk, Aznaouridis, Konstantinos1 (AUTHOR) ktsioufis@gmail.com, Aggeli, Konstantina1 (AUTHOR), Tsioufis, Konstantinos1 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 17, p5035. 21p.
Autor:
Zhan, Yufeng1 (AUTHOR), Li, Ning2 (AUTHOR) lining@smmu.edu.cn
Publikováno v:
Journal of Cardiothoracic Surgery. 7/2/2024, Vol. 19 Issue 1, p1-8. 8p.
Autor:
Rosillo Fairén, Alejandro1 alejandro.rosillo@universidadeuropea.es, Castro Acosta, Angélica María2 angelica.castro@universidadeuropea.es
Publikováno v:
Revista Vox Juris. 2024, Vol. 42 Issue 2, p171-189. 19p.
Autor:
Salas M; Servicio de Cardiología, Hospital Universitario de Bellvitge, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain., Roura G; Servicio de Cardiología, Hospital Universitario de Bellvitge, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: groura@bellvitgehospital.cat., Arzamendi D; Servicio de Cardiología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Berdejo J; Servicio de Cardiología, Hospital Universitario de Bellvitge, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain., Manito N; Servicio de Cardiología, Hospital Universitario de Bellvitge, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain., Gómez-Hospital JA; Servicio de Cardiología, Hospital Universitario de Bellvitge, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
Publikováno v:
Revista espanola de cardiologia (English ed.) [Rev Esp Cardiol (Engl Ed)] 2019 Nov; Vol. 72 (11), pp. 975-978. Date of Electronic Publication: 2019 Jun 11.
Autor:
Falip M; Epilepsy Unit, Department of Neurology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Rodriguez-Bel L; PET Division, Institute of Diagnostic Imaging (IDI), Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Castañer S; MRI Division, Institute of Diagnostic Imaging (IDI), Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Sala-Padró J; Epilepsy Unit, Department of Neurology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Miro J; Epilepsy Unit, Department of Neurology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Jaraba S; Epilepsy Unit, Department of Neurology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Casasnovas C; Neuromuscular Unit, Department of Neurology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Morandeira F; Immunology Unit, Biochemistry Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Berdejo J; Department of Cardiology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Carreño M; Epilepsy Unit, Department of Neurology, Hospital Clinic i Provincial, Barcelona, Spain.
Publikováno v:
Frontiers in neurology [Front Neurol] 2019 Jan 09; Vol. 9, pp. 1143. Date of Electronic Publication: 2019 Jan 09 (Print Publication: 2018).
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.